Business Context and Reporting Period
This Form 8-K filing by Optimumbank Holdings, Inc. covers the period ending April 20, 2015, with the earliest event reported on April 15, 2015. The filing addresses a corporate governance issue regarding the company's compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory compliance matter and does not contain financial performance data.
Material Changes
The material change reported is the company's failure to satisfy a continued listing rule due to a reduction in the number of Audit Committee members. Following the death of Board member and Audit Committee member Sam Borek on December 12, 2014, the committee was reduced to two members. This rendered the company non-compliant with Nasdaq Rule 4350(d)(2)(A), which mandates a minimum of three members. On April 15, 2015, the company received formal notification from NASDAQ regarding this non-compliance.
Outlook, Risks, and Management Commentary
Remediation Plan: The company intends to add at least one additional independent member to the Audit Committee to regain compliance.
Cure Period: NASDAQ has granted a cure period until the earlier of the company's next annual shareholders' meeting or December 12, 2015. If the next annual meeting is held before June 9, 2015, compliance must be evidenced by June 9, 2015.
Risks: Failure to cure the deficiency within the specified timeframe could result in the delisting of the company's securities from the Nasdaq Stock Market.
Investor Verification Checklist
- Verify the date of the next annual shareholders' meeting to determine the exact deadline for compliance.
- Monitor subsequent filings for the appointment of a new independent Audit Committee member.
- Confirm the company's continued listing status on Nasdaq following the cure period deadline.